[Treatment of advanced respiratory insufficiency using potassium canreonate (Aldactone). Preliminary report].
D000368:Aged; D002191:Canrenoic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011245:Pregnadienes / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D013997:Time Factors; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D011245:Pregnadienes; D002245:Carbon Dioxide; D002191:Canrenoic Acid; D010100:Oxygen
Zur Therapie der fortgeschrittenen respiratorischen Insuffizienz mit Canrenoat-Kalium (Aldactone) Vorläufige Mitteilung